Contributors
| Dr Neil Aaronson |
| The Netherlands Cancer Institute, Amsterdam, The Netherlands |
| Dr Giovanni Apolone |
| Mario Negri Institute, Milano, Italy |
| Paulo Carita |
| Sanofi-Aventis, Bagneux, France |
| Dr Olivier Chassany |
| Hôpital St Louis, Paris, France |
| Katrin Conway |
| Mapi Research Institute & Mapi Research Trust, Lyon, France |
| Dr. Dominique Dubois |
| Johnson & Johnson Pharmaceutical Services, Beerse, Belgium |
| Kirsten Gertsen |
| NV Organon, Oss, The Netherlands |
| Dr Asha Hareendran |
| Pfizer, Sandwich, UK |
| Bernard Jambon |
| Mapi Group, Lyon, France |
| Dr Fred Jost |
| F. Hoffman-La Roche Ltd, Basel Switzerland |
| Paul Kind |
| University of York, UK |
| Dr Patrick Marquis |
| Mapi Values, Boston, MA, USA |
| Dr Pauline McNulty |
| Johnson and Johnson, Raritan, NJ, USA |
| Dr Carolin Miltenburger |
| Schering AG, Berlin, Germany |
| Dr Elizabeth Piault |
| Mapi Values, Boston, MA, USA |
| Dr Margaret Rothman |
| Johnson and Johnson, Raritan, NJ, USA |
| Dr Pierre-Philippe Sagnier |
| Bayer PLC, Uxbridge, UK |
| Prof. Marianne Sullivan |
| Sahlgrenska University Hospital, Göteborg, Sweden |
| Dr. Maria Watson |
| GlaxoSmithKline, RTP, NC, USA |
| Dr Anders Ingelgard |
| AstraZeneca r&D, Moelndal, Sweden |
| Dr York Zoellner |
| Solvay Pharmaceuticals GmbH, Hannover, Germany |
|